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The direct binding protein(s) of ras p21 was (were) investigated in inside-out vesicles of human erythrocyte 
ghosts using the pure v-Kirsten (Ki)-ras ~21 synthesized in E. coli. The bound ras p21 was detected immuno- 
chemicallly using an anti-v-Ki-ras p21 monoclonal antibody. ras p21 bound to vesicles. Prior digestion of 
the vesicles with trypsin reduced this binding significantly. When ras p21 was laid over vesicle proteins im- 
mobilized on a nitrocellulose sheet by transfer from the gel of SDS-polyacrylamide gel electrophoresis, ras 
p21 bound to bands 4.2 and 6. ras p21 binding to these proteins was reduced by prior incubation of ras 
p21 with the purified band 4.2 or 6 protein. These results indicate that v-Ki-ras p21 can bind directly to 
bands 4.2 and 6 of human erythrocyte membranes as far as tested in an in vitro cell-free system. 
Oncogene; Plasma membrane; (ras ~21) 
1. INTRODUCTION 
The ra.s oncogene product, rus ~21, has been 
shown to induce transformation and DNA syn- 
thesis in various cell types [1,2], differentiation of 
PC-12 cells [3], maturation of Xenopus oocytes [4] 
and pinocytosis in rat embryo fibroblasts [5]. This 
protein has also been suggested to affect the 
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phospholipase AZ-induced arachidonic acid libera- 
tion, the phospholipase C-mediated hydrolysis of 
phosphoinositides and the adenylate cyclase- 
mediated formation of cyclic AMP in several 
mammalian cell types (review [6]). 
ras p21 possesses GTP-binding and GTPase ac- 
tivities and resides in the cytoplasmic face of the 
plasma membrane (review [7]). Although the mode 
of actibn of ras p21 is not known at all, it can be 
speculated, by analogy with other GTP-binding 
regulatory proteins for adenylate cyclase, cyclic 
GMP phosphodiesterase and phospholipase C, 
that ras p21 has two protein-interacting domains, 
the detector domain through which the function of 
ras p21 is affected by other protein(s) and the ef- 
fector domain which affects the function of target 
protein(s) (review [S]). It is important to identify 
ras p21-interacting proteins to understand the 
mode of action of this oncogene product, but it has 
not yet been clarified whether ras p21 binds to 
some specific membrane proteins. 
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The present studies were undertaken to in- 
vestigate ras p21-interacting membrane proteins. 
For this purpose, we used inside-out vesicles of 
human erythrocyte ghosts as a model system, since 
[i] erythrocyte membrane proteins have been in- 
vestigated and characterized most extensively 
(review [9]); (ii) inside-out vesicles are useful in 
studying ras p21 binding to the proteins on the 
cytoplasmic face of the plasma membrane and they 
are prepared most easily and reliably from 
erythrocytes; and (iii) the proteins functionally and 
structurally homologous to erythrocyte membrane 
proteins, such as spectrin [lO,l 11, ankyrin [12] and 
band 4.1 [ 131, are present in various types of cells 
and tissues, and erythrocyte membranes are often 
used as a model system to identify novel membrane 
proteins. 
This paper describes that v-Ki-ras p21 binds 
directly and specifically to bands 4.2 and 6 of 
human erythrocyte membranes in an in vitro cell- 
free system, although it remains to be clarified 
with which functional domains of ras p21 these 
two proteins interact. 
2. MATERIALS AND METHODS 
2.1. Materials 
The sealed inside-out vesicles of human 
erythrocyte ghosts were prepared by the method of 
Steck and Kant [14]. Vesicles were used after they 
were washed once in 50 mM Hepes at pH 8.0 and 
resuspended to 10 mg/ml of protein in the same 
buffer. Where indicated, vesicles (10 mg/ml of 
protein) were digested with 0.2 mg/ml of trypsin in 
100~1 of 50 mM Hepes at pH 8.0 for 1 h at 37°C 
and the reaction was terminated by the addition of 
1 mg/ml of trypsin inhibitor. v-Ki-ras p21 was syn- 
thesized in E. coli containing pHN121, a derivative 
of the Kirsten murine sarcoma virus clone HiHi3, 
as described in [ 151. This preparation (5 mg of pro- 
tein) was purified by a DEAE-Sephacel column 
(0.7 x 2.5 cm) equilibrated with buffer A (50 mM 
Hepes at pH 7.5, 1 mM EDTA and 1 mM DTT). 
After the column was washed with 3 ml buffer A, 
ras p21 was eluted with a 30-ml linear concentra- 
tion gradient of NaCl (O-O.8 M) in buffer A. Frac- 
tions of 0.5 ml each were collected. ras p21 
appeared in fractions 16-30. These fractions were 
pooled and diluted with 10 vols of buffer A and 
resubjected to the same column (0.7 x 1.2 cm) 
under the same conditions. ras p21 was eluted with 
1 ml of buffer A containing 1 M NaCl. This 
preparation of ras p21 (1 ml of 0.6 mg of protein) 
was nearly homogeneous as judged by protein 
staining with Coomassie brilliant blue on SDS- 
PAGE and was stocked at - 20°C in the presence 
of 50% glycerol until use. The anti-v-Ki-ras p21 
monoclonal antibody was made by injections of 
the purified antigen into mice. The isolation and 
screening of hybridomas were done by the stan- 
dard procedures [ 161. Among the several an- 
tibodies thus obtained, the antibody designated as 
CL 25-94 was used here. The detailed properties 
of this antibody will be described elsewhere (Shiku, 
H., in preparation). The band 4.2 protein was 
purified from fresh human erythrocyte ghosts by 
the method of Korsgren and Cohen [17] except 
that 0.3 mM sodium phosphate at pH 8.0 contain- 
ing 0.2 mM EDTA was used instead of 0.1 mM 
EGTA at pH 8.5 which was used previously for the 
solubilization of spectrin and actin. The purified 
band 4.2 protein was over 80% pure as judged by 
the same method described above. Rabbit muscle 
glyceraldehyde-3-phosphate dehydrogenase was 
from Boehringer, Mannheim. The band 6 protein 
of human erythrocyte membranes was identified to 
be this enzyme. The preparation of this enzyme 
was over 95% pure as judged by the same method 
described above. Biotinylated anti-mouse IgG, 
avidin and biotinylated peroxidase were from Vec- 
tor Laboratories. Other materials and chemicals 
were obtained from commercial sources. 
2.2. Assay for the ras p21 binding to the inside-out 
vesicles 
In this experiment, GTPyS-bound ras p21 was 
used. GTPyS-bound ras p21 was prepared by in- 
cubating ras p21 (3.3 pg of protein) in 30 ~1 of 
80 mM Hepes at pH 7.5 containing 1.7 mM 
GTPrS, 2 mM MgC12, 1.7 mM DTT, 0.17% BSA 
and 0.17 mM EDTA for 1 h at 30°C. All subse- 
quent procedures were performed at 4°C. ras p21 
was centrifuged at 16000 x g for 1 h to remove the 
aggregated form. The indicated amounts of ras 
p21 were incubated for 1.5 h with the inside-out 
vesicles (15 pg of protein) in 50 ,~l of buffer B 
(50 mM Hepes, pH 7.5, 1.2 mM MgC12, 1 mM 
DTT, 0.1 mM EDTA and 0.12 M KCl) containing 
1 mM GTPyS and 0.1% BSA. After incubation, 
the mixture was centrifuged at 16000 x g for 
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1.5 min. The pellet was washed with 200 ,uI of cold 
buffer B and centrifuged at 16000 x g for 1.5 min. 
The pellet was dissolved in 35 ~1 of 62 mM Tris- 
HCI, pH 6.8, containing 3% SDS, 2% 
2-mercaptoethanol, 5% glycerol and 0.05% 
bromophenol blue, and a 15-~1 aliquot was sub- 
jected to SDS-PAGE at room temperature. ras p21 
(O-300 ng of protein) was separately subjected to 
the same SDS-PAGE as a reference protein. After 
the electrophoresis, proteins on the gel were 
transferred to a nitrocellulose sheet, and ras p21 
was detected immunochemically as described 
below. 
2.3. SDS-PAGE and electrophoretic transfer of 
the proteins from the slab gel to a nitro- 
cellulose sheet 
SDS-PAGE was carried out on a 5-18~0, 11% 
or 8% polyacrylamide slab gel by the method of 
Laemmli [18]. The proteins on the gel were 
transferred to a nitrocellulose sheet by the method 
of Burnette [19]. Transfer was carried out in a 
transfer buffer (25 mM Tris-glycine, pH 8.3, and 
20% methanol) for 10 h at 4”C, at a constant 
voltage of 40 V (0.4 A). Under these conditions, 
the efficiency of electrophoretic transfer was 
greater than 70% for all proteins. The sheet was 
cut into strips corresponding to the individual 
lanes, and ras p21 was detected as described below. 
2.4. Immunochemical detection of ras p21 on a 
nitrocellulose sheet 
ras p21 on a nitrocellulose sheet was detected im- 
munochemically using the anti-ras p21 monoclonal 
antibody by the method of Hsu et al. [20]. After 
the electrophoretic transfer of the proteins from 
the gel to a nitrocellulose sheet, its strips (50 cm2 
of total area) were incubated in 75 ml TBS (50 mM 
Tris-HCI at pH 7.5 and 0.2 M NaCl) containing 
0.05% Tween 20 and 5% BSA for 1 h at 40°C. The 
strips were then incubated with the antibody in 
BSA-TBS (TBS containing 5% BSA) for 1 h at 
room temperature. They were washed 4 times with 
150 ml T-TBS (TBS containing 0.05% Tween 20) 
for 15 min at 40°C and incubated for 1 h at 40°C 
with 75 ml T-BSA-TBS (TBS containing 0.05% 
Tween 20 and 5% BSA). The strips were then in- 
cubated with biotinylated anti-mouse IgG (1: 50 
dilution) in BSA-TBS for 1 h at room temperature. 
They were washed 3 times with 150 ml T-TBS for 
10 min at 40°C and incubated with 75 ml T-BSA- 
TBS for 1 h at 40°C. The strips were then in- 
cubated with avidin-biotin peroxidase complex 
(1 :50 dilution) in BSA-TBS for 10 h at 4°C. They 
were washed 3 times with 150 ml T-TBS for 10 min 
at 40°C and once with 150 ml of TBS for 10 min 
at 40°C. ras p21 was detected by peroxidase reac- 
tion with 0.5 mg/ml of 4-chloro-1-naphthol in 
TBS containing 17% methanol and 0.01% Hz02 
for 15-30 min at room temperature. 
2.5. Overlay of the ras p21 on a nitrocellulose 
sheet 
Following the electrophoretic transfer of the 
proteins from the gel to a nitrocellulose sheet, its 
strips (50 cm2 of total area) were placed in 75 ml T- 
BSA-TBS. After the incubation for 4.5 h at 4O”C, 
the strips were overlaid with the GTPyS-bound ras 
p21 (6 pg of protein/ml) in BSA-TBS containing 
1 mM GTPyS, 1.2 mM MgC12, 1 mM DTT and 
0.1 mM EDTA, and incubated for 1 h at room 
ABCDE 
Fig.1. The rus p21 binding to vesicles. ras p21 (2 pug 
protein) was mixed with the intact or trypsin-digested 
vesicles (15 pg protein). The mixture was centrifuged 
and an aliquot of the pellet (6.4/cg of vesicle protein) 
was subjected to SDS-PAGE (polyacrylamide: 5-18070). 
After electrophoresis, the proteins were transferred to a 
nitrocellulose sheet and rus p21 immobilized on this 
sheet was stained immunochemically. Lanes: A, r-us p21 
plus intact vesicles; B, rus p21 without vesicles; C, rus 
p21 plus the trypsin-digested vesicles. In another 
experiment, rus p21 (200 ng protein) and intact vesicles 
(6.4 ,ug protein) were directly subjected to the same SDS- 
PAGE. After electrophoresis, ras p21 was detected as 
described above. Lanes: D, ras ~21; E, intact vesicles. 
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temperature. The GTPyS-bound ras p21 was 
prepared by incubating the ras p21 in the same 
solution for 1 h at 30°C. The strips were washed 6 
times with 150 ml T-TBS containing 1 mM MgClz 
for 15 min at 4O”C, and incubated with 75 ml T- 
BSA-TBS containing 1 mM MgClz for 1 h at 
4O“C. ras p21 bound to the proteins was detected 
immunochemicaliy as described above except that 
all the washing and blocking buffers used in this 
experiment contained additionally 1 mM MgClz. 
2.6. Determinations 
Protein was determined by the method of Lowry 
et al. [21]. The relative intensity of immunostain- 
ing bands was estimated by scanning at 560 nm us- 
ing a Shimadzu dual-wavelength chromatogram 
scanner, model CS-930. 
3. RESULTS 
with inside-out vesicles of human erythrocyte 
ghosts, and then centrifuged, ras P21 
coprecipitated with the vesicles (fig.1, lane A). 
Under the same condition, ras p21 did not 
precipitate in the absence of the vesicles (fig. 1, lane 
B). Prior digestion of vesicles with trypsin reduced 
the ras p21 binding to vesicles to a level 70-80% 
of that in intact vesicles (fig.1, lane C), indicating 
that ras p21 interacted at least partly with the vesi- 
cle protein(s). The antibody used in this experi- 
ment reacted specifically with ras p21 and did not 
react with proteins of the vesicles (fig.1, lanes 
D,E). Fig.2 shows the dose-dependent effect of the 
ra.s p21 binding to intact and trypsin-digested 
vesicles. ras p21 bound to both vesicles in a dose- 
dependent manner, but the levels of binding 
trypsin-digested vesicles were 70-80% of those to 
intact vesicles. Particularly, the binding of ras p21 
in smaller amounts to vesicles was more sensitive 
to tryptic digestion. 
When the GTPyS-bound v-Ki-ras p21 was mixed In the next set of experiments, the direct binding 
I I 
ras P21 (.u9 1 
Fig.2. Dose-dependent effect of the ras ~21 binding to 
intact and trypsin-digested vesicles. The ras p21 binding 
to intact or trypsin-digested vesicles was performed as 
described in the legend to fig.1 except that various 
amounts of ras p21 were added as indicated. (O---O) 
Intact vesicles; (M) the trypsin-digested vesicles. 
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Fig.3. Immunostaining of ras ~21 laid over intact and 
trypsin-digested vesicle proteins immobilized on a 
nitrocellulose sheet. The intact and trypsin-digested 
vesicles (3Opg protein) were subjected to SDS-PAGE 
(polyacrylamide: 11 or 8%). One of the lanes from the 
intact or trypsin-digested vesicle proteins was stained 
with Coomassie brilliant blue. The proteins in other 
lanes were transferred to a nitrocellulose sheet. ras p21 
was then laid over this sheet and protein-bound ras p21 
was stained immunochemically. Lanes: A-E, 11% 
polyacrylamide gel; F-J, 8% polyacrylamide gel; A and 
F, protein staining of the intact vesicle proteins; B and 
G, immunostaining of ras p21 laid over the intact vesicle 
proteins; C and H, immunostaining of the intact vesicle 
proteins without ras ~21 overlay; D and I, protein 
staining of the trypsin-digested vesicle proteins; E and J, 
immunostaining of the ras p21 laid over the trypsin- 
digested vesicle proteins. 
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protein(s) of the GTPyS-bound ras p21 in vesicles 
was investigated. For this purpose, ras p21 was laid 
over the proteins immobilized on a nitrocellulose 
sheet by transfer from the SDS-PAGE gel of the 
vesicles, and protein-bound ras p21 was detected as 
described above. The vesicle proteins were well 
resolved on this SDS-PAGE as judged by protein 
staining with Coomassie brilliant blue (fig.3, lanes 
A,F). ras p21 specifically bound to two proteins 
with molecular masses of 72 kDa and 35 kDa, 
which corresponded to protein bands designated as 
bands 4.2 and 6, respectively (fig.3, lanes B,G). 
The GDP-bound form of ras p21 similarly bound 
to these two proteins (not shown). The GDP- 
bound form of ras p21 was prepared by the same 
method as the GTPyS-bound form. In the absence 
of ras ~21, the antibody did not react with proteins 
of the vesicles (fig.3, lanes C,H). Prior digestion of 
vesicles with trypsin caused disappearance of 
Table 1 
Inhibition by the purified band 4.2 and 6 proteins of the 
rus p21 binding to these bands immobilized on a 
nitrocellulose sheet 
Addition Relative intensity at 
560 nm (Yo) 
Band 4.2 Band 6 
Control 100 100 
Band 4.2 protein 6 75 69 
12 41 37 
24 20 17 
Band 6 protein 3 65 62 
6 38 35 
12 20 18 
The intact vesicles (30ag of protein) were subjected to 
SDS-PAGE (polyacrylamide: 8%). After electropho- 
resis, proteins were transferred to a nitrocellulose sheet. 
ras p21 (0.6 pg protein) was preincubated with indicated 
amounts of band 4.2 protein or band 6 protein in 0.1 ml 
BSA-TBS containing 1 mM GTPrS, 1.2 mM MgClz, 
1 mM DTT, 0.1 mM EDTA and 0.1 mM EGTA for 
10 min at 3O”C, laid over a nitrocellulose sheet, and 
stained immunochemically as described in the legend to 
fig.3. Band 4.2 and 6 proteins were used after dialysis 
for 12 h at 4°C against a large volume of 5 mM sodium 
phosphate, pH 8.0, containing 0.5 mM EGTA and 
0.5 mM DTT. The values are means (n = 3) expressed as 
percentage of control 
several protein bands including band 4.2 as judged 
by protein staining with Coomassie brilliant blue 
on SDS-PAGE (fig.3, lanes D,I), but did not affect 
the protein staining of band 6. This treatment 
abolished the ras p21 binding to band 4.2, but did 
not affect the ras p21 binding to band 6 nor pro- 
duced new ras p21-bound bands (fig.3, lanes E,J). 
Essentially the same results were obtained when 
the human erythrocyte ghosts were used instead of 
their vesicles (not shown). The vesicles were mostly 
depleted of spectrin and actin whereas the ghosts 
contained them in large amounts. 
The addition of either the purified band 4.2 or 
6 protein to ras p21 during the overlay period in- 
hibited the ras p21 binding to bands 4.2 and 6 im- 
mobilized on a nitrocellulose sheet in a 
dose-dependent manner (table 1). 
4. DISCUSSION 
The present results indicate that ras p21 binds 
directly to bands 4.2 and 6 of the inside-out 
vesicles of human erythrocyte ghosts as far as 
tested in an in vitro cell-free system. This binding 
is not simply non-specific, because ras p21 binds 
specifically to bands 4.2 and 6 among many vesicle 
proteins and this binding is inhibited by the 
purified intact band 4.2 and 6 proteins. 
It has been speculated that ras p21 has two 
protein-interacting domains, the detector and ef- 
fector domains [8]. It is unknown with which func- 
tional domains of rus p21 bands 4.2 and 6 interact. 
However, since both the GTPyS- and GDP-bound 
forms of ras p21 similarly bind to bands 4.2 and 6 
and the GTP- and GDP-bound forms are con- 
sidered to be active and inactive forms, respective- 
ly [7], it is likely that bands 4.2 and 6 interact with 
domain(s) other than the effector domain. One 
such possibility is the detector domain. It is also 
conceivable that ras p21 has an additional protein- 
interacting domain to the detector and effector do- 
mains, which determines the specific localization 
of this oncogene product on the plasma membrane 
and that bands 4.2 and 6 interact with such a 
domain. 
Since it has not been shown whether ras p21 
functions in mature erythrocytes, the physiological 
significance of the binding of this protein to bands 
4.2 and 6 in this particular cell type is not known 
at present. Band 6 is a glyceraldehyde-3-phosphate 
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dehydrogenase, one of the glycolytic enzymes, and 
is present in most mammalian tissues. It is not 
known whether band 4.2 is also present in other 
tissues, but it is possible that band 4.2 or a band 
4.2-like protein is present in other cell types since 
the proteins structurally and immunologically 
related to spectrin [ 10,111, ankyrin [12] and band 
4.1 [13] have been identified in various cell types. 
Therefore, it is conceivable that rus p21 may in- 
teract with bands 4.2 and 6 in the cells containing 
these proteins. Tissue distribution of band 4.2 or a 
band 4.2-like protein and the ras p21 binding to 
bands 4.2 and 6 in cells other than erythrocytes are 
now being investigated. 
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